Kiki Chang1,2, Melissa DelBello3, Amy Garrett4, Ryan Kelley1, Meghan Howe1,2, Cal Adler3, Jeffrey Welge3, Stephen M Strakowski5, Manpreet Singh1,6. 1. 1 Pediatric Bipolar Disorders Program, Stanford University School of Medicine , Stanford, California. 2. 2 Private Practice, Menlo Park, California. 3. 3 Division of Bipolar Disorders Research, University of Cincinnati School of Medicine , Cincinnati, Ohio. 4. 4 Health Science Center, The University of Texas , San Antonio, Texas. 5. 5 Dell Medical School, The University of Texas , Austin, Texas. 6. 6 Pediatric Mood Disorder Program, Stanford University School of Medicine , Stanford, California.
Abstract
OBJECTIVES: Prior studies have shown that youth with bipolar disorder demonstrate neurofunctional changes in key prefrontal and subcortical brain regions implicated in emotional regulation following treatment with pharmacological agents. We recently reported a large response rate (>60%) to quetiapine (QUET) for treating depressive symptoms in adolescents with bipolar depression. This study investigates the neurofunctional effects of QUET using functional magnetic resonance imaging (fMRI). METHODS:Thirty-three unmedicated subjects, 10-17 years of age, with a current depressive episode (Children's Depression Rating Scale-Revised [CDRS-R] > 40) associated with bipolarI or II disorder were recruited in a two-site randomized, placebo (PBO)-controlled trial of QUET monotherapy for treatment of bipolar depression in adolescents. Twenty-three of these participants (nine male) underwent an MRI scan at baseline, then were randomized to QUET or PBO, followed for 8 weeks, and at the end of their study participation underwent another MRI scan. During the fMRI scan, subjects viewed negative and neutral pictures and rated the valence of each picture. RESULTS:Sixteen subjects had usable data at both time points: 10 subjects randomized toQUET, and 6 randomized to PBO. For QUET subjects, lower baseline activation in the left dorsolateral prefrontal cortex (p < 0.005) and higher baseline activation in the left ventrolateral prefrontal cortex (p = 0.0024) predicted greater improvement in CDRS-R scores from baseline to follow-up. When QUET and PBO groups were combined (n = 16), region-of-interest activation did not significantly predict change in CDRS-R. CONCLUSIONS: Baseline activation patterns in dorsal and ventral portions of the prefrontal cortex that are critical for the regulation of emotion-predicted response, but only within the QUET group. Thus, specific medications may be more effective in the context of specific prefrontal activation patterns in youth with bipolar depression. Larger studies of these youth would help to clarify the effects of QUET on brain activation.
RCT Entities:
OBJECTIVES: Prior studies have shown that youth with bipolar disorder demonstrate neurofunctional changes in key prefrontal and subcortical brain regions implicated in emotional regulation following treatment with pharmacological agents. We recently reported a large response rate (>60%) to quetiapine (QUET) for treating depressive symptoms in adolescents with bipolar depression. This study investigates the neurofunctional effects of QUET using functional magnetic resonance imaging (fMRI). METHODS: Thirty-three unmedicated subjects, 10-17 years of age, with a current depressive episode (Children's Depression Rating Scale-Revised [CDRS-R] > 40) associated with bipolar I or II disorder were recruited in a two-site randomized, placebo (PBO)-controlled trial of QUET monotherapy for treatment of bipolar depression in adolescents. Twenty-three of these participants (nine male) underwent an MRI scan at baseline, then were randomized to QUET or PBO, followed for 8 weeks, and at the end of their study participation underwent another MRI scan. During the fMRI scan, subjects viewed negative and neutral pictures and rated the valence of each picture. RESULTS: Sixteen subjects had usable data at both time points: 10 subjects randomized to QUET, and 6 randomized to PBO. For QUET subjects, lower baseline activation in the left dorsolateral prefrontal cortex (p < 0.005) and higher baseline activation in the left ventrolateral prefrontal cortex (p = 0.0024) predicted greater improvement in CDRS-R scores from baseline to follow-up. When QUET and PBO groups were combined (n = 16), region-of-interest activation did not significantly predict change in CDRS-R. CONCLUSIONS: Baseline activation patterns in dorsal and ventral portions of the prefrontal cortex that are critical for the regulation of emotion-predicted response, but only within the QUET group. Thus, specific medications may be more effective in the context of specific prefrontal activation patterns in youth with bipolar depression. Larger studies of these youth would help to clarify the effects of QUET on brain activation.
Authors: Robert L Findling; Idil Cavuş; Elizabeth Pappadopulos; Douglas G Vanderburg; Jeffrey H Schwartz; Balarama K Gundapaneni; Melissa P DelBello Journal: J Child Adolesc Psychopharmacol Date: 2013-10-10 Impact factor: 2.576
Authors: Hugh M Jones; Michael J Brammer; Mary O'Toole; Tess Taylor; Ruth I Ohlsen; Richard G Brown; Richard Purvis; Steven Williams; Lyn S Pilowsky Journal: Biol Psychiatry Date: 2004-12-15 Impact factor: 13.382
Authors: Andrew K Davis; Melissa P DelBello; James Eliassen; Jeffrey Welge; Thomas J Blom; David E Fleck; Wade A Weber; Kelly B Jarvis; Emily Rummelhoff; Stephen M Strakowski; Caleb M Adler Journal: Bipolar Disord Date: 2014-10-31 Impact factor: 6.744
Authors: Nick C Patel; Kim M Cecil; Stephen M Strakowski; Caleb M Adler; Melissa P DelBello Journal: J Child Adolesc Psychopharmacol Date: 2008-12 Impact factor: 2.576
Authors: Amy S Garrett; David J Miklowitz; Meghan E Howe; Manpreet K Singh; Tenah K Acquaye; Christopher G Hawkey; Gary H Glover; Allan L Reiss; Kiki D Chang Journal: Prog Neuropsychopharmacol Biol Psychiatry Date: 2014-10-02 Impact factor: 5.067
Authors: Kathleen Ries Merikangas; Lihong Cui; G Kattan; Gabrielle A Carlson; Eric A Youngstrom; Jules Angst Journal: Arch Gen Psychiatry Date: 2012-09
Authors: Manpreet K Singh; Akua F Nimarko; Amy S Garrett; Aaron J Gorelik; Donna J Roybal; Patricia D Walshaw; Kiki D Chang; David J Miklowitz Journal: J Am Acad Child Adolesc Psychiatry Date: 2020-08-01 Impact factor: 8.829
Authors: Barthelemy Diouf; Claudia Wing; John C Panetta; Donnie Eddins; Wenwei Lin; Wenjian Yang; Yiping Fan; Deqing Pei; Cheng Cheng; Shannon M Delaney; Wei Zhang; Erik J Bonten; Kristine R Crews; Steven W Paugh; Lie Li; Burgess B Freeman; Robert J Autry; Jordan A Beard; Daniel C Ferguson; Laura J Janke; Kirsten K Ness; Taosheng Chen; Stanislav S Zakharenko; Sima Jeha; Ching-Hon Pui; Mary V Relling; M Eileen Dolan; William E Evans Journal: Clin Transl Sci Date: 2021-05-31 Impact factor: 4.689